ClinConnect ClinConnect Logo
Search / Trial NCT06804200

Prospective Validation of AKI Prediction

Launched by ADAM C DZIORNY · Jan 27, 2025

Trial Information

Current as of July 26, 2025

Not yet recruiting

Keywords

Machine Learning Pediatrics Critical Care

ClinConnect Summary

This clinical trial is focused on improving the way we predict Acute Kidney Injury (AKI) in children who are admitted to the Pediatric Intensive Care Unit (PICU) or Pediatric Cardiac Intensive Care Unit (PCICU). The researchers want to test a special scoring system called the Pediatric Early AKI Risk Score to see how accurately it can identify patients at risk for AKI within the first 72 hours of being in the ICU. They will do this by collecting data in a way that the clinical team cannot see, to ensure unbiased results. The goal is to have the scoring system identify AKI correctly more than 70% of the time.

To be eligible for this study, patients must be between 30 days and 17 years old and must be admitted to one of the specialized intensive care units mentioned. However, those who are discharged less than 12 hours after admission or who already have AKI when they arrive will not be included. Participants in the trial can expect that their information will be used to help improve future care for children at risk of kidney injury. This study is currently not recruiting participants, but it aims to gather important insights for better treatment options in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients admitted to the Pediatric Intensive Care Unit or Pediatric Cardiac Intensive Care Unit
  • Age \> 30 days and \< 18 years
  • Exclusion Criteria:
  • Discharged less than 12 hours after admission
  • AKI at 12 hours of admission by KDIGO Serum Criteria

About Adam C Dziorny

Adam C. Dziorny is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic approaches, Mr. Dziorny oversees the design, implementation, and management of clinical studies, ensuring adherence to regulatory standards and ethical guidelines. His expertise in trial methodology, coupled with a strong emphasis on collaboration with research institutions and healthcare professionals, fosters a robust environment for scientific discovery. Through meticulous planning and execution, Adam C. Dziorny aims to contribute to the development of novel treatments that address unmet medical needs.

Locations

Rochester, New York, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported